Loading…
Employees: 1,794
Size Sichuan Goldstone Asia Pharmaceutical (300434.SZ) is a China Industrials company (Miscellaneous Manufacturing) with a market value of $745M, the 2925th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥12.37 on 6 Nov 2026.
Performance Over six months the shares gained 8.1%, against -22.6% for the median peer and -16.4% for the China market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue fell 1.3% over the last twelve months (peer median +6.8%); the operating margin is 17.9% (peer median 6.8%).
Valuation It trades at 4.3× enterprise value to sales against a peer median of 2.4× (6th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 12% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +6 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 0.1 points below its cost of capital (9.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.04B | CN¥1.03B | CN¥1.09B | CN¥1.20B | CN¥1.23B |
| Revenue growth | — | -6% | -9% | -3% | — |
| Gross profit | CN¥676M | CN¥540M | CN¥566M | CN¥683M | CN¥705M |
| EBITDA | n/a | CN¥242M | CN¥231M | CN¥341M | CN¥368M |
| Net income | CN¥176M | CN¥132M | CN¥91.8M | CN¥126M | CN¥219M |
| Free cash flow | CN¥162M | CN¥109M | CN¥87.0M | CN¥86.0M | CN¥271M |
| Capital expenditure | CN¥97.3M | CN¥99.6M | CN¥72.9M | CN¥66.1M | CN¥54.1M |
| Total debt | CN¥112M | CN¥125M | CN¥144M | CN¥175M | CN¥93.0M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300434.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -0.3% | -8.6% | 2nd highest of 21 |
| 6-month return | +8.1% | -22.6% | 4th highest of 21 |
| Distance from 52-week high | -14.2% | -39.0% | 2nd highest of 21 |
| Revenue growth (TTM) | -1.3% | +6.8% | 4th lowest of 21 |
| Operating margin | 17.9% | 6.8% | 4th highest of 21 |
| EV / Sales | 4.3× | 2.4× | 6th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 12.2% | 7.5% | 6th most demanding of 14 |
| Growth delivered (Del g) | +6.2% | +3.6% | 6th highest of 14 |
| Hurdle (Req g minus delivered) | +5.9 pp | +3.4 pp | 5th most demanding of 14 |
| ROIC minus cost of capital | -0.1 pp | -2.2 pp | 10th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Sichuan Goldstone Asia Pharmaceutical 300434.SZ | China | $745M | +8% | -1% | 18% | 4.3× | 12.2% | +6.2% |
| Daoming Optics & Chemical 002632.SZ | China | $740M | -28% | -10% | 12% | 3.3× | 7.5% | +3.3% |
| Fuling Technology 001356.SZ | China | $756M | -22% | +17% | 6% | 2.2× | n/a | n/a |
| Apex Dynamics 4583.TW | Taiwan | $775M | -58% | +14% | 33% | 7.6× | 4.5% | +1.1% |
| RHI Magnesita India RHIM.NS | India | $789M | -13% | +8% | 7% | 1.8× | 27.1% | +24.1% |
| Unilumin 300232.SZ | China | $796M | -23% | +1% | 0% | 0.8× | 6.4% | +10.3% |
| Changyuan Technology 600525.SS | China | $799M | -24% | +7% | -7% | 1.0× | -12.4% | +5.1% |
| Hubei Huaqiang High-Tech 688151.SS | China | $800M | -22% | +13% | -5% | 3.8× | 47.9% | -5.6% |
| Jiangsu Boiln Plastics 301003.SZ | China | $688M | -11% | +7% | 20% | 6.4× | 21.2% | +3.6% |
| Jinhua Chunguang Technology 603657.SS | China | $687M | +16% | +9% | -3% | 2.0× | n/a | n/a |
| Zhejiang Tiantie Science & Technology 300587.SZ | China | $683M | -43% | +24% | -4% | 3.3× | n/a | n/a |
| Zhejiang Kaier New Materials 300234.SZ | China | $816M | +73% | -17% | -9% | 18.4× | n/a | n/a |
| Zhejiang Goldensea Hi-Tech 603311.SS | China | $823M | +28% | +3% | 7% | 5.8× | n/a | n/a |
| Riverstone AP4.SI | Singapore | $824M | -13% | -4% | 25% | 2.9× | 2.1% | -12.8% |
| Jiangyin Huaxin Precision Technology 603370.SS | China | $661M | -39% | +11% | 7% | 2.6× | n/a | n/a |
| Blue Sail Medical 002382.SZ | China | $861M | -24% | +23% | 7% | 1.3× | -6.5% | -6.1% |
| Shenzhen Jame Technology 300868.SZ | China | $878M | -36% | +8% | -7% | 8.1× | n/a | n/a |
| Genuit GEN.L | United Kingdom | $897M | +8% | +4% | 12% | 1.4× | 12.4% | +8.6% |
| Jiangsu Changhai Composite Materials 300196.SZ | China | $897M | -25% | +3% | 11% | 2.0× | 3.8% | +9.0% |
| Guangdong Sunwill Precising Plastic 002676.SZ | China | $609M | -27% | +1% | 4% | 1.8× | 8.4% | +10.9% |
| Finolex Industries FINPIPE.NS | India | $932M | -20% | +3% | 14% | 1.6× | 13.0% | +3.5% |